Science Explorer Interactive view Map
Company · Kawasaki · Japan

OncoTherapy Science (Japan)

oncotherapy.co.jp/enROR OpenAlex
Research works
48
▼ 23% vs 2013–17
Citations
955
19.7 per fractional work
Top-10% rate
19.2%
record average 16.5%
Open access
47%
world 28%

Not ranked overall: OncoTherapy Science (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.13× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 7.80× its world share, 0 worksImmunology and Micro…Neuroscience: 0.48× its world share, 0 worksNeuroscienceChemistry: 4.44× its world share, 0 worksChemistryComputer Science: 0.10× its world share, 0 worksComputer ScienceEngineering: 1.12× its world share, 1 worksEngineeringMaterials Science: 1.00× its world share, 0 worksMaterials SciencePhysics and Astronomy: 2.09× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.11× its world share, 0 worksHealth ProfessionsMedicine: 2.07× its world share, 2 worksMedicineDecision Sciences: 2.41× its world share, 0 worksDecision SciencesPsychology: 0.76× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.8×. Every wedge is a field page.

Which keywords describe research at OncoTherapy Science (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Cancer Immunotherapy, Apoptosis, Antigen Presentation, Regulation, Oxidative Stress, Innate Immunity and Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer7▲ 9.9×13 topics
  2. Cancer Immunotherapy5▲ 72×3 topics
  3. Oxidative Stress5▲ 5.5×13 topics
  4. Apoptosis5▲ 24×6 topics
  5. Antigen Presentation4▲ 90×2 topics
  6. Regulation4▲ 14×3 topics
  7. Immunity4▲ 23×3 topics
  8. Innate Immunity4▲ 23×3 topics
  9. Metabolism4▲ 12×3 topics
  10. Dendritic Cells3▲ 61×1 topic
  11. FoxO Transcription Factors3▲ 168×1 topic
  12. Tumor Antigen3▲ 87×1 topic
  13. cell cycle regulation3▲ 1036×1 topic
  14. Tumor Microenvironment3▲ 18×4 topics
  15. Immunotherapy3▲ 9.5×6 topics
  16. Transcriptional Regulation2▲ 19×4 topics
  17. Cancer Progression2▲ 19×3 topics
  18. Nanowires2▲ 18×3 topics
  19. Chemotherapy2▲ 5.4×7 topics
  20. Immune Checkpoint Blockade2▲ 69×1 topic
  21. PD-1 and PD-L12▲ 69×1 topic
  22. Semiconductors2▲ 15×2 topics
  23. Prognostic Factors2▲ 7.7×7 topics
  24. Band Parameters2▲ 24×2 topics
  25. Neoadjuvant Therapy2▲ 13×4 topics
  26. Glycosylation1▲ 13×2 topics
  27. Inflammation1▲ 1.23×8 topics
  28. Cell Proliferation1▲ 29×2 topics
  29. III-Nitrides1▲ 63×1 topic
  30. Light-Emitting Diodes1▲ 22×1 topic
  31. Angiogenesis1▲ 5.8×4 topics
  32. CAR T Cells1▲ 55×1 topic
  33. Chimeric Antigen Receptor1▲ 55×1 topic
  34. Lymphoma1▲ 16×2 topics
  35. Cancer Therapy1▲ 3.5×5 topics
  36. Epigenetic Regulation1▲ 11×2 topics
  37. Photodetectors1▲ 24×2 topics
  38. Epigenetic Reprogramming1▲ 27×2 topics
  39. Epitaxial Growth1▲ 26×2 topics
  40. Metastasis1▲ 6.3×3 topics

Which research topics does OncoTherapy Science (Japan) publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Click Chemistry and Applications, Protein Degradation and Inhibitors and Acute Myeloid Leukemia Research.

Cancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksClick Chemistry and Appl…0Click Chemistry and Applications: 0 fractional worksProtein Degradation and …0Protein Degradation and Inhibitors: 0 fractional worksAcute Myeloid Leukemia R…0Acute Myeloid Leukemia Research: 0 fractional worksImmune cells in cancer: 0 fractional worksCancer Cells and Metastasis: 0 fractional worksSARS-CoV-2 and COVID-19 …0SARS-CoV-2 and COVID-19 Research: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksAdvanced MEMS and NEMS Technologies: 0 fractional worksAcoustic Wave Resonator …0Acoustic Wave Resonator Technologies: 0 fractional works
OncologyOrganic ChemistryMolecular BiologyHematology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 0 works
  2. 2 Click Chemistry and Applications Organic Chemistry 0 works
  3. 3 Protein Degradation and Inhibitors Molecular Biology 0 works
  4. 4 Acute Myeloid Leukemia Research Hematology 0 works
  5. 5 Immune cells in cancer Immunology 0 works
  6. 6 Cancer Cells and Metastasis Oncology 0 works
  7. 7 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  8. 8 Immunotherapy and Immune Responses Immunology 0 works
  9. 9 Advanced MEMS and NEMS Technologies Electrical and Electronic Engineering 0 works
  10. 10 Acoustic Wave Resonator Technologies Biomedical Engineering 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.2%not open52.8%

World: 28% of research is openly available.

with international co-authors54.6%domestic only45.4%

World: 19% is written across borders.

How has OncoTherapy Science (Japan)'s research output changed?

Output in 2018–2022 was 23% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Kawasaki

All research institutions in Kawasaki

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.